Trial Condition(s):
Study to evaluate the effect of Angeliq® and ActivelleTM on hemostasis parameters in healthy postmenopausal women
91203
Not Available
Not Available
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | Status |
---|
A multi-center, open-label, randomized study to evaluate the effect of Angeliq® and ActivelleTM on hemostasis in 60 healthy postmenopausal women over 7 treatment cycles
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A